Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPaypoint Regulatory News (PAY)

Share Price Information for Paypoint (PAY)

Share Price is delayed by 15 minutes
Get Live Data
551.50    2.50 (0.46%)
Bid:
550.50
Ask:
552.50
Spread: 2.00 (0.363%)
Market Cap: £332.24m
PAY Live PriceLast checked at - London Stock Exchange

Intraday Paypoint Share Chart

Form 8.3 - PayPoint plc

15 Dec 2022 15:10

RNS Number : 8889J
Legal & General Investment Mgmnt Ld
15 December 2022
Β 

FORM 8.3

Β 

PUBLIC DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Β 

Legal And General Investment Management Ltd.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Β 

Legal And General Investment Management Ltd.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Β 

PayPoint Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

Β 

No

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

Β 

14 December 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Β 

No

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

Β 

ORD GBP 0.0033

Β 

Β 

Interests

Short positions

Β 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Β 

1,109,679

Β 

1.60%

Β 

Β 

Β 

(2) Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

1,109,679

Β 

1.60%

Β 

Β 

Β 

Β 

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Β 

N/A

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

Β 

ORD GBP 0.0033

Β 

Sale

Β 

6,892

Β 

GBP 5.08

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

./

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Date of disclosure:

Β 

15 December 2022

Contact name:

Β 

Laszlo Benedek

Telephone number:

Β 

029 2011 4065

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETBKPBKPBDDOBD
Date   Source Headline
6th Dec 202210:54 amRNSForm 8.5 (EPT/NON-RI) Paypoint Plc
5th Dec 20225:00 pmGNWHolding(s) in Shares
5th Dec 20228:49 amRNSForm 8.5 (EPT/RI)
2nd Dec 20223:33 pmRNSForm 8.3 - PayPoint plc
2nd Dec 20228:40 amRNSForm 8.5 (EPT/RI)
2nd Dec 20227:00 amRNSPublication of Scheme Document
1st Dec 20224:13 pmGNWRULE 2.9 ANNOUNCEMENT
1st Dec 202210:30 amGNWTotal voting rights
1st Dec 20229:02 amRNSForm 8.5 (EPT/RI)
30th Nov 20222:56 pmRNSForm 8.3 - PayPoint plc
30th Nov 20229:33 amRNSForm 8.5 (EPT/RI)
25th Nov 20228:59 amRNSForm 8.5 (EPT/RI)
24th Nov 20221:34 pmRNSForm 8.3 - Paypoint Plc
24th Nov 202211:42 amRNSForm 8.3 - Paypoint PLC
24th Nov 20227:00 amGNWResults for the half year ended 30 September 2022
23rd Nov 202210:13 amRNSForm 8.3 - PayPoint plc
22nd Nov 20225:16 pmRNSForm 8.3 - PayPoint PLC
22nd Nov 20225:14 pmRNSForm 8.3 - PayPoint PLC
22nd Nov 20225:11 pmRNSForm 8.3 - PayPoint Plc
22nd Nov 20223:20 pmRNSForm 8.3 - PayPoint Plc
22nd Nov 20222:59 pmRNSForm 8.3 - PayPoint PLC
22nd Nov 20222:55 pmRNSForm 8.3 - PayPoint PLC
22nd Nov 20222:52 pmRNSForm 8.3 - PayPoint Plc
22nd Nov 202212:30 pmGNWPayPoint plc : Director/PDMR Shareholding
21st Nov 20223:20 pmRNSForm 8.3 - PayPoint Plc
21st Nov 202210:30 amRNSForm 8.5 (EPT/NON-RI) Paypoint Plc
21st Nov 20229:30 amGNWForm 8 (OPD) PayPoint Plc-Public Opening Position Disclosure under Rules 8.1 & 8.2 of the Takeover Code
18th Nov 20225:40 pmRNSForm 8.3 - PayPoint plc
18th Nov 20229:42 amRNSForm 8.5 (EPT/RI) - PayPoint PLC
17th Nov 20223:20 pmRNSForm 8.3 - PayPoint plc
17th Nov 20223:20 pmRNSForm 8.3 - PayPoint Plc
17th Nov 20221:37 pmRNSForm 8.3 - PayPoint plc
17th Nov 20229:26 amRNSForm 8 (DD) - PayPoint PLC
16th Nov 20222:21 pmRNSForm 8.3 - PayPoint plc
16th Nov 20221:06 pmRNSForm 8.3 - PayPoint plc
16th Nov 202210:08 amRNSForm 8 (DD) - PayPoint PLC
16th Nov 20228:24 amRNSForm 8.5 (EPT/NON-RI) Paypoint Plc
15th Nov 20223:26 pmRNSForm 8.3 - PayPoint plc
15th Nov 20229:33 amRNSForm 8.5 (EPT/NON-RI) Paypoint Plc
15th Nov 20229:25 amRNSForm 8 (DD) - [PayPoint]
15th Nov 20227:00 amRNSForm 8 (DD) - [PayPoint]
14th Nov 20226:00 pmGNWHolding(s) in Shares
14th Nov 20223:50 pmRNSForm 8.3 - PayPoint Plc
14th Nov 20223:22 pmRNSForm 8.3 - PAYPOINT PLC
14th Nov 20223:21 pmRNSForm 8.3 - PayPoint plc
11th Nov 20224:05 pmGNWHolding(s) in Shares
11th Nov 20223:47 pmRNSForm 8.3 - PayPoint plc
11th Nov 20223:44 pmRNSForm 8.3 - PayPoint plc
11th Nov 20223:39 pmRNSForm 8.3 - PayPoint plc
11th Nov 20223:33 pmRNSForm 8.3 - PayPoint plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.